Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
About this item
Full title
Author / Creator
SCORED Investigators , Bhatt, Deepak L , Szarek, Michael , Pitt, Bertram , Cannon, Christopher P , Leiter, Lawrence A , McGuire, Darren K , Lewis, Julia B , Riddle, Matthew C , Inzucchi, Silvio E , Kosiborod, Mikhail N , Cherney, David Z.I , Dwyer, Jamie P , Scirica, Benjamin M , Bailey, Clifford J , Díaz, Rafael , Ray, Kausik K , Udell, Jacob A , Lopes, Renato D , Lapuerta, Pablo and Steg, P. Gabriel
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a trial involving 10,584 patients with diabetes and chronic kidney disease, sotagliflozin resulted in fewer total deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo. Diarrhea, mycotic infections, and diabetic ketoacidosis occurred with sotagliflozin.
Alternative Titles
Full title
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Authors, Artists and Contributors
Author / Creator
Bhatt, Deepak L
Szarek, Michael
Pitt, Bertram
Cannon, Christopher P
Leiter, Lawrence A
McGuire, Darren K
Lewis, Julia B
Riddle, Matthew C
Inzucchi, Silvio E
Kosiborod, Mikhail N
Cherney, David Z.I
Dwyer, Jamie P
Scirica, Benjamin M
Bailey, Clifford J
Díaz, Rafael
Ray, Kausik K
Udell, Jacob A
Lopes, Renato D
Lapuerta, Pablo
Steg, P. Gabriel
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2477703057
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2477703057
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2030186
